Fractyl Health, Inc. Capital Expenditures
Fractyl Health, Inc. (GUTS) reported Capital Expenditures of $557.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $3.00K, a 98.71% decline year-over-year.
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $8.00K, a 96.24% decline year-over-year.
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $98.00K, a 62.31% decline year-over-year.
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $448.00K, a 57.70% decline year-over-year.
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $557.00K, a 68.44% decline from fiscal 2024.
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.76M, a 391.64% increase from fiscal 2023.
- Fractyl Health, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $359.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $11.00K derived: sum of 2 quarters · filed 2026-03-24 | $109.00K derived: sum of 3 quarters · filed 2026-08-10 | $557.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $106.00K derived: sum of 2 quarters · filed 2026-08-10 | $554.00K 10-Q · filed 2025-11-12 | $787.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $546.00K 10-Q · filed 2026-08-10 | $779.00K derived: sum of 3 quarters · filed 2026-08-10 | $992.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $448.00K 10-Q · filed 2026-05-12 | $681.00K derived: sum of 2 quarters · filed 2026-05-12 | $894.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.15M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $446.00K derived: sum of 2 quarters · filed 2026-03-24 | $706.00K derived: sum of 3 quarters · filed 2026-03-24 | $1.76M 10-K · filed 2026-03-24 |
| 2024-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $473.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.53M 10-Q · filed 2025-11-12 | $1.67M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.32M 10-Q · filed 2025-08-12 | $1.46M derived: sum of 3 quarters · filed 2025-08-12 | $1.60M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-13 | $1.20M derived: sum of 2 quarters · filed 2025-05-13 | $1.34M derived: sum of 3 quarters · filed 2025-05-13 | $1.40M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $284.00K derived: sum of 2 quarters · filed 2025-03-03 | $339.00K derived: sum of 3 quarters · filed 2025-03-03 | $359.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $203.00K derived: sum of 2 quarters · filed 2024-11-12 | $223.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $75.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $20.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |